Expounding on Obesity

• Disappointing Outcomes Show Futility of Weight Loss Studies Self-reported diet studies should be evaluated with great skepticism. A better way to evaluate is finding a diet that works for the individual.
  Medscape Diabetes & Endocrinology, February 04, 2025
• If New Obesity Medications Work, Why Do So Many Stop Them? Recent research suggests that patients prescribed GLP-1s don’t fill their prescriptions or stop taking them. Yoni Freedhoff, MD, discusses the obstacles to patient adherence.
  Medscape Diabetes & Endocrinology, January 31, 2025
• Obesity Medications Don’t Explain Decrease in Obesity Rates Recent reports that the decrease in obesity rates is due to increased prescribing of antiobesity medications are unfounded. Yoni Freedhoff, MD, explains why it’s just not possible.
  Medscape Diabetes & Endocrinology, January 17, 2025
• Will Redefining Obesity Help Those Who Have It? What matters is whether obesity’s formal definition will help reduce weight bias and increase access to treatment for those who need it.
  Medscape Diabetes & Endocrinology, January 15, 2025
• No, Diet and Exercise Are Not Better Than Drugs for Obesity There’s no debate that diet and exercise aren’t more effective for people with obesity than antiobesity medications, contends Yoni Freedhoff, MD.
  Medscape Diabetes & Endocrinology, December 06, 2024
• Can We Fight Social Media’s Promotion of Junk Food? Advertising sugary cereals and salty snacks to kids is rampant on social media. Do bans on such marketing create a decrease in the demand for these processed foods?
  Medscape Diabetes & Endocrinology, December 05, 2024
• Much Ado About the Diagnosis of Obesity BMI, body roundness index, and adiposity have all been used to diagnose obesity, but the question remains of not only how best to diagnose obesity but also how best to treat it.
  Medscape Diabetes & Endocrinology, November 26, 2024
• Treat People With Obesity Like People, Not Their Disease Two prominent medical associations recommend treating people with obesity like actual people. Yoni Freedhoff, MD, explains why this is another form of bias.
  Medscape Diabetes & Endocrinology, August 28, 2024
• Should 'South Park: The End of Obesity' Be Required Viewing? A new South Park episode tackles obesity, including the continuing demand for antiobesity medications. Yoni Freedhoff, MD, explains why it should be required viewing in medical school.
  Medscape Diabetes & Endocrinology, June 28, 2024
• 'Ozempic Burgers' Offer Indulgences to People With Obesity Nestlé recently announced they would sell food targeted for customers on anti-obesity medications. Yoni Freedhoff, MD, explains why this move should be celebrated.
  Medscape Diabetes & Endocrinology, June 04, 2024
• 'Stop Teaching' Kids It's Their Fault They're Fat New draft recommendations focus on lecturing children with obesity about diet while ignoring medications or surgery. Dr Yoni Freedhoff says this is another form of weight bias.
  Medscape Diabetes & Endocrinology, January 12, 2024
• 'Patients Fail' Despite Benefits of Sustained Weight Loss Obesity needs to be treated like every other chronic noncommunicable disease rather than as personal responsibility, contends Yoni Freedhoff, MD.
  Medscape Diabetes & Endocrinology, August 25, 2023
• 10 Ways Docs Sabotage Their Patients' Weight Loss Journeys Rather than encouraging their patients' weight loss journeys, physicians, perhaps unknowingly, inhibit their progress. Yoni Freedhoff expounds on the ways that physicians sabotage their patients.
  Medscape Diabetes & Endocrinology, July 11, 2023
• Can't Stop the Hyperbole About Diet Interventions The news proclaiming the success of the UK's diet-based protocol in weight mitigation in people with type 2 diabetes overexaggerates the findings. Yoni Freedhoff, MD, expounds on why it's misleading.
  Medscape Diabetes & Endocrinology, May 18, 2023
• Double Standards Continue in Antiobesity Meds Discourse Recent reports are criticizing researchers for not disclosing their funding when talking about new antiobesity medications. Dr Yoni Freedhoff argues that this is another form of weight bias.
  Medscape Diabetes & Endocrinology, April 12, 2023
• New Antiobesity Drugs Will Benefit Many. Is That Bad? New antiobesity medicines are being deemed too costly for insurers despite the success patients have had with losing weight and improving their health. Dr Yoni Freedhoff ponders why.
  Medscape Diabetes & Endocrinology, March 31, 2023
• What Happens When Newer Weight Loss Meds Are Stopped? Anti-obesity meds are a "game-changer" for many people with obesity, but what happens when people stop taking them? Dr Jaime Almandoz explains.
  Medscape Diabetes & Endocrinology, March 27, 2023
• Will New Guidelines Widen the Gap in Treating Kids' Obesity? The new AAP guidelines advocating for "aggressive" treatment in managing obesity in kids may only further widen the gap between the "haves and have-nots," argues Liliana Aguayo.
  Medscape Diabetes & Endocrinology, March 13, 2023
• Calories of Love: Grandparents Push Sugar on Grandkids A new study found grandparents are guilty of pushing sugary treats on their grandkids. Yoni Freedhoff shares his family's experience with sugar pushers and offers alternative treat recommendations.
  Medscape Diabetes & Endocrinology, February 24, 2023
• Weight Bias Affects Views of Kids' Obesity Recommendations New recommendations for "aggressive treatment" for children with obesity have sparked outrage among many. Dr Yoni Freedhoff says the extreme reaction doesn't surprise him but is unwarranted.
  Medscape Diabetes & Endocrinology, January 26, 2023